Form 4: Medicine Man Technologies Director Kathy Vrabeck Receives Stock Grant for Board Service

Sentiment:

SEC Form 4 Filing


Kathy Vrabeck, a director at Medicine Man Technologies, received 32,012 shares of common stock as compensation for her service on the board.

Summary

  • Kathy Vrabeck, a director of Medicine Man Technologies, Inc. (SHWZ), reported a transaction on March 29, 2024, where she acquired 32,012 shares of common stock.
  • These shares were granted as compensation for her service on the board of directors.
  • The shares were valued at $26,250, based on the closing price of the common stock on the OTCQX Best Market on March 28, 2024.
  • Following the transaction, Vrabeck directly owns 59,958 shares of Medicine Man Technologies.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (stock grant to a director), which is generally neutral to slightly positive as it aligns director interests with shareholders.

Positives

  • The stock grant aligns the director's interests with those of the shareholders.

Industry Context

Stock grants to board members are a common practice in publicly traded companies to incentivize and compensate them for their service.

Stakeholder Impact

  • The stock grant could have a minor dilutive effect on existing shareholders.

Key Dates

DateDescription
03/28/2024Date used to calculate the value of the stock grant based on the closing price of the common stock on the OTCQX Best Market.
03/29/2024Date of the transaction where Kathy Vrabeck acquired shares of common stock.
04/02/2024Date of signature for the power of attorney document.

Keywords

Form 4, beneficial ownership, director, stock grant, Medicine Man Technologies, SHWZ, Kathy Vrabeck

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.